Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Class I Recall for Children’s Allergy Swabs
07/07/2022
Buzzagogo Inc is voluntarily recalling a nasal swab used to lessen seasonal allergy symptoms due to contamination concerns.
Buzzagogo Inc is voluntarily recalling a nasal swab used to lessen seasonal allergy symptoms due to contamination concerns.
Buzzagogo Inc is voluntarily...
07/07/2022
Pharmacy Learning Network
News
Superpotent Injection Under Class I Recall
07/07/2022
A Class I recall has been issued for inotersen injection following a test result suggesting superpotency.
A Class I recall has been issued for inotersen injection following a test result suggesting superpotency.
A Class I recall has been issued...
07/07/2022
Pharmacy Learning Network
News
Interdisciplinary Team Uses Systematic Process to Treat Veterans With COVID-19
06/30/2022
A systematic process involving physicians, pharmacists, and nurses optimized timely and appropriate treatment for veterans with COVID-19.
A systematic process involving physicians, pharmacists, and nurses optimized timely and appropriate treatment for veterans with COVID-19.
A systematic process involving...
06/30/2022
Veterans Health Today

Advertisement

News
Immunization Uptake Higher When Pharmacists Are Involved
06/30/2022
Immunization rates are positively impacted by pharmacist participation in immunization efforts, according to study authors.
Immunization rates are positively impacted by pharmacist participation in immunization efforts, according to study authors.
Immunization rates are...
06/30/2022
Pharmacy Learning Network
News
First Aid Antiseptic Recalled Over Leaky Containers
06/30/2022
Vi-Jon LLC is voluntarily recalling 3 million bottles of isopropyl alcohol due to defective containers.
Vi-Jon LLC is voluntarily recalling 3 million bottles of isopropyl alcohol due to defective containers.
Vi-Jon LLC is voluntarily...
06/30/2022
Pharmacy Learning Network
News
Testosterone Injection Recalled
06/30/2022
A Class II recall has been issued for several lots of testosterone injection due to concerns over product impurities and sterility.
A Class II recall has been issued for several lots of testosterone injection due to concerns over product impurities and sterility.
A Class II recall has been...
06/30/2022
Pharmacy Learning Network

Advertisement

News
Contraceptive Injection Recalled
06/23/2022
Sun Pharmaceutical Industries Inc is voluntarily recalling a contraceptive injection due to concerns about product sterility.
Sun Pharmaceutical Industries Inc is voluntarily recalling a contraceptive injection due to concerns about product sterility.
Sun Pharmaceutical Industries...
06/23/2022
Pharmacy Learning Network
News
Hand Sanitizer Recalled Over Contaminants
06/23/2022
Hand sanitizer distributed by Hand Cleansing Gel is under a Class II recall.
Hand sanitizer distributed by Hand Cleansing Gel is under a Class II recall.
Hand sanitizer distributed by...
06/23/2022
Pharmacy Learning Network
News
Asthma Medication Recalled
06/23/2022
A Class II recall has been issued for a prescription anti-inflammatory medication used to treat patients with asthma.
A Class II recall has been issued for a prescription anti-inflammatory medication used to treat patients with asthma.
A Class II recall has been...
06/23/2022
Pharmacy Learning Network

Advertisement

News
Type 2 Diabetes Medication Use Potentially Boosted by Pharmacist Involvement in Care
06/21/2022
Utilization of SGLT2 inhibitors and GLP-1 receptor agonists was greater in patients with type 2 diabetes mellitus who were seen by a pharmacist-led diabetes clinic as opposed to a primary care clinic alone.
Utilization of SGLT2 inhibitors and GLP-1 receptor agonists was greater in patients with type 2 diabetes mellitus who were seen by a pharmacist-led diabetes clinic as opposed to a primary care clinic alone.
Utilization of SGLT2 inhibitors...
06/21/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use